Ratings by Cantor Fitzgerald (Kirsten Kluska)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/13/2026 | Monopar Therapeutics | MNPR | Downgrade | Neutral (Overweight) |
114.46 (116.21) |
1.53% | Details | |
| 7/15/2026 | Monopar Therapeutics | MNPR | Maintain | Overweight (Overweight) |
|
Details | ||
| 1/21/2026 | Monopar Therapeutics | MNPR | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/27/2025 | Monopar Therapeutics | MNPR | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/7/2025 | Monopar Therapeutics | MNPR | New Coverage | Overweight (N/A) |
36.25 (114.46) |
215.75% | Details |
